Should You Sell Novavax Inc (NVAX) Stock Friday Morning?

Novavax Inc (NVAX) is higher by Friday morning, with the stock gaining 1.27% in pre-market trading to 5.57. NVAX's short-term technical score of 21 indicates that the stock has traded less bullishly over the last month than 79% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, the stock ranks higher than 35% of stocks. Novavax Inc has fallen 17.42% over the past month, closing at $7.06 on November 3. During this period of time, the stock fell as low as $5.35 and as high as $7.49. NVAX has an average analyst recommendation of Buy. The company has an average price target of $19.60.

NVAX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on NVAX!

See Full NVAX Report

Novavax Inc has a Long-Term Technical rank of 5. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 95% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, NVAX ranks better than 126% of stocks.

Important Dates for Investors in NVAX:

-Novavax Inc is set to release earnings on 2024-02-07. Over the last 12 months, the company has reported EPS of $-6.39. -We do not have a set dividend date for Novavax Inc at this time. Click Here To Get The Full Report on Novavax Inc (NVAX)